Team:Cornell/Description

From 2011.igem.org

(Difference between revisions)
(References)
(Microfluidic Device)
Line 18: Line 18:
We made use of the biotin-streptavidin binding interaction in fixing our biotinylated enzymes to the PDMS channel surfaces. E. coli has a natural mechanism encoded by the birA gene to produce biotin and biotinylate proteins. Thus, by avitagging enzymes of interest and adding biotin to the bacterial culture to enhances this natural mechanism, we functionalized our enzymes for biotin-streptavidin binding to the microfluidic device.
We made use of the biotin-streptavidin binding interaction in fixing our biotinylated enzymes to the PDMS channel surfaces. E. coli has a natural mechanism encoded by the birA gene to produce biotin and biotinylate proteins. Thus, by avitagging enzymes of interest and adding biotin to the bacterial culture to enhances this natural mechanism, we functionalized our enzymes for biotin-streptavidin binding to the microfluidic device.
-
Using standard chemical procedures from Gleghorn et al.¹ provided by Dr. Kirby (Cornell University, Mechanical and Aerospace Engineering), NeutrAvidin was bonded to the surface of PDMS channels. NeutrAvidin is  
+
Using standard chemical procedures from Gleghorn et al<sup>1</sup> provided by Dr. Kirby (Cornell University, Mechanical and Aerospace Engineering), NeutrAvidin was bonded to the surface of PDMS channels. NeutrAvidin is interchangeable with streptavidin, with a similar tetramer structure that binds with biotin in four regions, with a dissociation constant Kd = 10-15 M. NeutrAvidin can bind greater than 12 µg of biotin per mg protein.<sup>2</sup>
-
 
+
-
 
+

Revision as of 02:36, 29 September 2011

Project Description | Future Directions | Business Development | Outreach/HP | Safety

Contents

The BioFactory

Cornell’s BioFactory aims to develop a simple and efficient method for the construction of enzyme-immobilized surfaces capable of multi step chemical reactions.

As more chemical production techniques begin to utilize enzymatic reactions, genetic engineers must consider ways to resolve competing side reactions and the toxic accumulation of intermediates, reduce purification costs, and correctly express non-native enzymes or proteins in bacteria. In some cases, such challenges could be more easily resolved by simply extracting the molecular metabolic mechanisms and produce the target compound in a cell-free environment. We believe a cell-free system for biosynthesis can resolve these issues and still use the power of bacteria to help build devices capable of producing complex organic compounds.

Over the summer, Cornell's iGEM team engineered strains of E. Coli to produce modified enzymes from the biosynthetic pathway of Violacein which were immobilized on the surface of microfluidic devices and capable of converting an initial feed of substrate into prodeoxyvioalcein, a direct intermediate of the violacein pathway. The microfluidic chips were designed, built and tested in the lab using Cornell’s modern cleanroom and nanofabrication facilities. We additionally designed and began construction of a light-induced apoptosis system capable of lysing bacteria cultures, producing the necessary enzymes without the use of expensive reagents or extensive protocols.

Project Description-1 Cornell2011.jpg
Project Description-2 Cornell2011.jpg Project Description-3 Cornell2011.jpg

Microfluidic Device

GFPTestCoating Cornell2011.jpg

We made use of the biotin-streptavidin binding interaction in fixing our biotinylated enzymes to the PDMS channel surfaces. E. coli has a natural mechanism encoded by the birA gene to produce biotin and biotinylate proteins. Thus, by avitagging enzymes of interest and adding biotin to the bacterial culture to enhances this natural mechanism, we functionalized our enzymes for biotin-streptavidin binding to the microfluidic device.

Using standard chemical procedures from Gleghorn et al1 provided by Dr. Kirby (Cornell University, Mechanical and Aerospace Engineering), NeutrAvidin was bonded to the surface of PDMS channels. NeutrAvidin is interchangeable with streptavidin, with a similar tetramer structure that binds with biotin in four regions, with a dissociation constant Kd = 10-15 M. NeutrAvidin can bind greater than 12 µg of biotin per mg protein.2


Microfulidics section Cornell2011.jpg

Violacein Pathway

We chose to use the violacein pathway fully characterized by Balibar et. al.² as our model enzyme-mediated-reaction. The violacein pathway involves five enzymes (VioA, VioB, VioC, VioD, and VioE) in the conversion of L-Tryptophan into violacein, a purple chromophore. This pathway was an especially attractive candidate for our project not only because it has been thoroughly characterized in E. coli, but also because relatively few enzymes are needed to convert a cheap, common substrate into a visualizable product. Furthermore, only three of the five enzymes (VioA, VioB, and VioE) are required to produce a colored product. Even with the exception of Vios C and D, L-Tryptophan is converted into prodeoxyviolacein, a green pigment (Figure 3A in Balibar et. al.²). Thus, we chose to biotinylate only VioA, VioB, and VioE to provide proof-of-concept that enzymes bound to our microfluidic devices may be used to facilitate enzyme-mediated reactions.

Violacein Pathway

Cornell11 Viopathway.jpg

Light-Induced Lysis

Cornell11 LightlysisDNA.png We would like to develop a genetic switch that is sensitive to specific wavelengths of visible light and use this gene expression system to lyse bacterial cells solely with light. The genetic light sensor is based on Chris Voigt’s “Multichromatic Control of Gene Expression in Escherichia coli,”³ which uses visible green light at 532 nm to induce specific gene expression. The system is composed of a light-activated surface protein, which autophosphorylates an intermediate chromophore and a reporter protein that binds to a specific promoter and is activated by the chromophore.

The genes to be expressed downstream of the promoter make up a lysis cassette derived from the lambda phage and developed by Prof. Young at Texas A&M University. This lysis system is very useful because the incubation period after gene expression is on the order of 50 minutes, and the actual lysis occurs within one minute thereafter. Our hope is to lyse bacterial cultures within a known timeframe and with specificity to green light.


DNA Assembly Methods

References

1. Gleghorn, J. P. et al. (2010). Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential
immunocapture (GEDI) and a prostate-specific antibody. Lab Chip, 10, 27-29. doi:10.1039/B917959C
2. Balibar, C. J. and Walsh, C. T. (2006). In Vitro Biosynthesis of Violacein from L-Tryptophan by the Enzymes VioA−E from Chromobacterium Violaceum.
Biochemistry, 45(51), 15444-15457. doi:10.1021/bi061998z
3. Tabor, J. J., Levskaya, A., & Voight, C. A. (2010). Multichromatic Control of Gene Expression in Escherichia coli.
Journal of Molecular Biology, 405(2),315-324. doi:10.1016/j.jmb.2010.10.038